Platelet-rich plasma

Platelet-rich plasma

Crown Aesthetics Completes Rebrand to ProGen PRP Eclipse™, Combining Two Industry Leading Platelet Rich ...

Crown Aesthetics, a division of Crown Laboratories, Inc., has recently announced the completion of the rebranding of ProGen PRP. This rebranding effort combines two of the industry's leading platelet-rich plasma (PRP) solutions, offering enhanced benefits to patients and medical professionals alike.

Platelet-rich plasma therapy is a cutting-edge treatment that utilizes the patient's own blood to stimulate healing and regeneration. The blood is processed to separate the platelet-rich plasma, which is then injected into the targeted area. This concentrated plasma contains growth factors and other bioactive substances that promote tissue repair and regeneration.

ProGen PRP Eclipse™ is the result of the merger between Eclipse PRP and ProGen PRP, two highly respected names in the field of regenerative medicine. This rebranding aims to streamline the product offerings and provide a unified solution for medical professionals seeking the benefits of PRP therapy.

With ProGen PRP Eclipse™, medical professionals can expect improved product quality, ease of use, and enhanced patient outcomes. This comprehensive PRP system offers advanced technology and optimized protocols, ensuring consistent and reliable results.

Platelet-rich plasma therapy has gained popularity in various medical fields, including aesthetics, orthopedics, and dermatology. Its applications range from skin rejuvenation and hair restoration to joint and tendon healing. The rebranding of ProGen PRP Eclipse™ signifies a significant step forward in the field of regenerative medicine, providing medical professionals with an innovative and reliable solution for their patients.